New article: Time to Gamble on Mannkind's Afrezza

[savzak]

m.gurufocus.com/news_read.php?id=253025

[babaoriley]

Gamble? LOL!

[mannmade]

Couple of personal notes/corrections to the article below as I understand things...

1.) Patents on Afrezza are protected until 2031 not 2020 as indicated below

2.) the Pain medicine is being developed in partnership with another company on Torrey Pines and is being designed as an opiate substitute.

They are claiming that when finished developing it will be non-addictive and cannot overdose on it so can take as much as needed to manage pain. And it is very fast acting going through lungs on same technosphere molecular platform as Afrezza.

I have no recommendation here but if they do what they say they are able to make come true then this will likely be bigger than Afrezza.

3.) You buy mnkd not Afrezza as indicated below when investing in the stock of Mannkind

4.) They are also working on a flu vaccine with the Cricket inhaler and the technosphere platform which could also be very big as it does not need refrigeration and can be self dosed so that can be distributed in advance of a flu pandemic and will also have wide use in 3rd world countries (no refrigeration required) with no refrigeration in many areas.

5.) They are also working on a basal insulin patch to replace the morning and evening used of needles… As well as using Afrezza in the Samsun trials of the Artifical Pancreas.

6.) and finally they have a very robust oncology research dept that was shuttered to cut costs/burn rate to focus on getting Afrezza to market.

However, please note while all of this is extremely promising and if comes to fruition the future of “Mannkind” will indeed be bright… It all depends on getting approval for Affrezza as the first and nearest term product to market. The company currently burns about 11m per month with enough cash on hand to get to August or so of this year. So before anything else can be developed Afrezza needs to get to market preferably with a global BP partner.